首页 | 本学科首页   官方微博 | 高级检索  
     

伊贝沙坦对早期糖尿病肾病患者尿转化生长因子β_1的影响
引用本文:冯毅,粱干雄. 伊贝沙坦对早期糖尿病肾病患者尿转化生长因子β_1的影响[J]. 现代医院, 2006, 6(11): 16-17
作者姓名:冯毅  粱干雄
作者单位:中山市人民医院,广东,中山,528400
摘    要:目的观察血管紧张素Ⅱ受体拮抗剂(ARB)伊贝沙坦对早期糖尿病肾病患者尿转化生长因子β1(TGF-β1)排泄的影响,探讨其治疗糖尿病肾病的可能机理。方法72例早期糖尿病肾病患者被随机分为对照组(n=34)和伊贝沙坦组(n=38),治疗12周后测定两组治疗前后尿白蛋白排泄率(UAER)、尿TGF-β1的水平。结果伊贝沙坦组UAER、尿TGF-β1水平均有明显下降。结论伊贝沙坦对糖尿病肾病有保护作用,其机理可能与下调肾脏局部尿TGF-β1水平有关。

关 键 词:糖尿病肾病  转化生长因子β1  伊贝沙坦

THE INFLUENCE OF IRBESARTAN ON URINARY TRANSFORMING GROWTH FACTOR-β1 IN EARLY DIABETIC NEPHROPATHY
FENG Yi,LIANG Ganxiong. THE INFLUENCE OF IRBESARTAN ON URINARY TRANSFORMING GROWTH FACTOR-β1 IN EARLY DIABETIC NEPHROPATHY[J]. Modern Hospital, 2006, 6(11): 16-17
Authors:FENG Yi  LIANG Ganxiong
Abstract:Objective To observe the influence of irbesartan on urinary transforming growth factor-beta1(TGF-β_1) in early diabetic nephropathy and explore their therapeutic mechanism. Methods Seventy-tow type 2 diabetic patients with early diabetic nephropathy were randomly divided into control group and irbesartan treatment group. Urinary albumin excretion and urinary TGF-β_1 was measured. Results Urinary albumin excretion and urinary TGF-β_1 levels in irbesartan treatment group were significantly decreased after 12 weeks treatment. Conclusion Irbesartan have renoprotective effect in patients with early diabetic nephropathy. The decrease of TGF-β_1 concentration in renal tissue may be a mechanism for this action.
Keywords:Diabetic nephropathy   Transforming growth factor - Betal   Irbesartan
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号